United States Immunosuppressant Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Immunosuppressant Markets, Executive SummaryIntroduction to the U.S. Immunosuppressants MarketIntroduction to the U.S. Immunosuppressants MarketObjectives and PurposeReport Scope and SegmentationSummary of Major FindingsSummary of Major FindingsTotal Revenue ForecastsAnalysis by Major SegmentCompetitive AnalysisMergers and AcquisitionsUnited States Immunosuppressant Markets, Market Engineering Research MethodologyResearch ScopeObjectives and PurposeMarket Engineering Forecasting MethodologyOverviewStrategic Significance of the Market Engineering ForecastJudging Credibility and Accuracy of Market Engineering ForecastsForecast AssumptionsGlossary of TermsList of DefinitionsList of AcronymsUnited States Immunosuppressant Markets, Industry ChallengesIdentification of Challenges Facing the Immunosuppressants IndustryIdentification of Challenges Facing the Immunosuppressants IndustryDevelopment of Safer Immunosuppressants Increases Market PotentialLack of Treatments for Moderate to Severe AutoimmuneDisease Provides Unlimited Opportunities for New DrugsDevelopment of More Selective or Specific Immunosuppressants Improves Clinical OutcomesDevelopment of Effective, Novel Vaccines Increases DemandDevelopment of Immune Tolerance Products Thwarts Demand for Conventional ImmunosuppressantsDevelopment of Orally Available Drugs Enhances Consumer AppealDevelopment of Tissue Transplants Requiring Immunosuppressants Propels DemandDevelopment of Less Costly Therapeutics Encourages Widespread UseDevelopment of Safe and Effective Xenotransplants Aids Public Acceptance of XenotransplantsUnited States Immunosuppressant Markets, Forecast for the Organ Transplant Immunosuppressants Market Market Overview and DefinitionsOverviewDefinitionScope/SegmentationHistory, Applications/UseMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversDevelopment of Safer Immunosuppressants Increases Market PotentialDevelopment of More Selective Immunosuppressants Yields Improved OutcomesGrowing Demand for Organ Transplants by Aging Baby BoomersIntroduction of XenotransplantsBoosts Demand for ImmunosuppressantsIntroduction of Artificial Organs Requires Immunosuppressive AgentsShortage of Donor Organs Limiting Number of Transplant ProceduresAlternatives to Kidney Transplantation Are Available Reduction in Incidence of Acute Rejection Lowering Treatment DemandProduct Life Cycle Decreased Due to CompetitionMarket Engineering and Revenue Forecasts (1995-2005)Demand AnalysisMajor Technical and Market TrendsRevenuesTechnology TrendsCompetitive AnalysisCompetitive StructureCompetitive FactorsMarket Share Winners and WhyMarket Share Losers and WhyProduct AnalysisProducts on the MarketProducts in Clinical TrialsUnited States Immunosuppressant Markets, Forecast for the Classical Autoimmune Diseases Immunosuppressants Market Market Overview and DefinitionsOverviewDefinitionScope/SegmentationAutoimmune Disease OverviewHistory, Applications/UseMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket RestraintsMarket Engineering and Revenue Forecasts (1995-2005)Demand AnalysisRevenuesTechnology TrendsTechnology Assessment Based on Interventional CategoriesCompetitive AnalysisCompetitive StructureCompetitive FactorsProduct AnalysisProduct AnalysisProducts on the MarketProducts in Clinical TrialsUnited States Immunosuppressant Markets, Forecast for the Emerging Autoimmune Diseases Immunosuppressants Market Market Overview and DefinitionsOverviewDefinitionScope/SegmentationEmerging Autoimmune Disease OverviewEmerging Autoimmune Disease Treatment OverviewHistory, Applications and UseMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversDevelopment of Safer Immunosuppressants Stimulates InnovationLack of Treatments for Moderateto Severe Disease Sparks Drug DiscoveryMarket Success of Recent New Product Introductions Fuels CompetitionDevelopment of More SelectiveImmunosuppressants Targets AdvantageDevelopment of Vaccines Advantageous for Targeted AttackMarket RestraintsMarket RestraintsHigh Cost of Therapy Limiting Demand for Less Severe StagesLack of Full Knowledge on Control of Immune Response Delays New Product IntroductionsInsidious Onset of Disease Limiting Early InterventionEpisodic Occurrence of Disease Activity Makes Therapy DifficultDevelopment of Genetic Cures Depleting MarketMarket Engineeringand Revenue Forecasts (1995-2005)Demand AnalysisRevenuesTechnology TrendsCompetitive AnalysisCompetitive StructureCompetitive FactorsProduct AnalysisProduct AnalysisProducts in Clinical TrialsUnited States Immunosuppressant Markets, Market Engineering StrategyWhat Is Market Engineering Strategy?Measurement-Driven Strategy GenerationMarket Engineering Strategic RecommendationsCorporate Management and Business DevelopmentMarketing and Sales DepartmentsResearch and Development DepartmentsMarket Engineering Awards for the Immunosuppressants MarketsFrost & Sullivan's 2000 Market Engineering AwardsFrost & Sullivan's 2000 Market Engineering AwardsMarket Engineering AwardsMarket Engineering AwardsAward Category: Product Innovation Award Category: Competitive StrategyAward Category: Customer Service Leadership Award Category: Product Line Strategy




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.